Generic name:dengue tetravalent vaccine, live (subcutaneous route) [ DEN-gay-tet-ra-VAY-lent-vak-SEEN, lyve ]
Drug class:Viral vaccines
Medically reviewed by Drugs.com. Last updated on Dec 16, 2021.
Commonly used brand name(s)
In the U.S.
- Dengvaxia
Available Dosage Forms:
- Powder for Suspension
Therapeutic Class: Vaccine, Live
Uses for Dengvaxia
Dengue tetravalent vaccine, live is used to prevent dengue disease in children 9 to 16 years of age with a previous laboratory-confirmed dengue infection and who are living in endemic (where the disease is common) areas.
This vaccine is to be given only by or under the direct supervision of your doctor.
Before using Dengvaxia
In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies have not been performed on the relationship of age to the effects of dengue tetravalent vaccine, live in children younger than 9 years of age. Safety and efficacy have not been established.
Geriatric
Appropriate studies have not been performed on the relationship of age to the effects of dengue tetravalent vaccine, live in the elderly 65 years of age and older. Safety and efficacy have not been established.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
